INDIA – BDR Pharma, one of India’s leading generic pharmaceutical companies, has launched the country’s first generic-midostaurin under the brand name MSTARIN, which is indicated in rare, difficult-to-treat cancers. The…
Read MoreINDIA – BDR Pharma, one of India’s leading generic pharmaceutical companies, has launched the country’s first generic-midostaurin under the brand name MSTARIN, which is indicated in rare, difficult-to-treat cancers. The…
Read More